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Dear Editor,
Quality of life and health-related
quality of life measures
In the editorial by Madsen (1) the SF-36 and the
St George’s Respiratory Questionnaire (SGRQ) are
rightfully considered health-related quality of life
(HRQOL) measures. However, HRQOL is not the
same as quality of life (QOL). HRQOL, previously
called health status, refers to the influence of disease
on physical, emotional and social functioning. In
contrast, QOL is peoples’ perception of their life or their
evaluation of functioning (e.g. 2–4). The differences
between both concepts are (i) in HRQOL lower levels
of functioning are equated with lower QOL, whereas
empirical findings reflect high perceived QOL in spite of
low levels of functioning, (ii) QOL encompasses the
respondent’s own perception of aspects of their life,
while health status asks respondents about the
presence or frequency of behaviour and feelings, and
(iii) QOL has a much wider scope than the physical,
emotional and social domains (2–5). The disadvantage
of measuring a limited number of aspects in a study
into problems among a patient population is that
existing problems might be ignored simply because
the patients are not asked about them. What you do
not measure will not appear (6). In our opinion, QOL
is a useful concept to measure in patient populations
because it is broad, and patients may indicate what
they perceive as problems instead of what physicians
think patients’ problems are [see difference (i) above].
The choice between using a HRQOL or a QOL
measure should always be based on the purpose of the
study and researchers should know what they want
to assess.
The persistent remark that the SF-36 is the gold
standard is only based on the fact that it is a reliable
and valid measure in a number of diseases in the U.S.A.
Even the applicability of a generic measure must be
proven for each new medical field that it is used in. For
instance, Chang et al. (7) have tested the SF-36 in
interstitial lung diseases. When a questionnaire has good
psychometric properties in one language, in the case
of HRQOL usually in English, this does not automatically
mean that this will also be the case after translations
into other languages. Psychometric studies are always
necessary in order to test reliability and validity of
translated studies. An important aspect in this context
that was not mentioned by Madsen (1) is the cultural
appropriateness of a questionnaire in another culture/0954-6111/01/020159+05 $35?00/0language. A questionnaire that contains sensible items
in culture/language X may be incomplete or over-
complete in culture/language Y. That is, the questionnaire
may lack aspects or questions relevant to culture/
language Y that play no role in culture/language X.
The opposite may also be true: the questionnaire
contains aspects or questions irrelevant for culture/
language Y (8). These issues cannot be solved by
calculating reliability and validity data but need another
approach.
DE VRIES* AND M. DRENT{
*Tilburg University,
Department of Psychology,
P.O. Box 90153,
5000 LE Tilburg, The Netherlands.
E-mail: j.devries@kub.nl
{University Hospital Maastricht,
Department of Pulmonology,
P.O. Box 5800,
6202 AZ Maastricht, The Netherlands.
E-mail: mdr@slor.azm.nl
References
1. Madsen F. Quality of life questionnaires for all
respiratory diseases, every language and ethnic mino-
rities. Are alternatives available? Respir Med 2000; 94:
187–189.
2. Wirnsberger RM, De Vries J, Breteler MHM, et al.
Evaluation of quality of life in sarcoidosis patients.
Respir Med 1998; 92: 750–756.
3. De Vries J, Seebregts A, Drent M. Assessing health
status and quality of life in idiopathic pulmonary
fibrosis. Which measure should be used? Respir Med
2000; 94: 273–278.
4. De Vries J, Van Heck GL. The World Health
Organization Quality of Life assessment instrument
(WHOQOL-100): validation study with the Dutch
version. Eur J Psychol Assess 1997; 13: 164–178.
5. De Vries J, Drent M. Measuring quality of life in
interstitial lung disease. Chest 2000; 118: 275.
6. De Vries J. Beyond health status: construction and
validation of the Dutch WHO quality of life instrument.
Tilburg: Tilburg University. Doctoral thesis, 1996
7. Chang JA, Curtis JR, Parick DL, Raghu G.
Assessment of health-related quality of life in patients
with intersititial lung disease. Chest 1999; 116:
1175–1182.
8. De Vries J. Quality of life assessment. In: Vingerhoets
AJJM, ed. Behavioral Medicine 2000; in press.# 2001 HARCOURT PUBLISHERS LTD
